Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects
暂无分享,去创建一个
[1] Giorgio Pennazza,et al. Volatile signature for the early diagnosis of lung cancer , 2016, Journal of breath research.
[2] R. Cataneo,et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.
[3] Hossam Haick,et al. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] A. Amann,et al. Suitability of different polymer bags for storage of volatile sulphur compounds relevant to breath analysis. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] J. Austin,et al. Prediction of lung cancer using volatile biomarkers in breath. , 2007, Cancer biomarkers : section A of Disease markers.
[6] T. Walles,et al. Comparison of volatile organic compounds from lung cancer patients and healthy controls—challenges and limitations of an observational study , 2016, Journal of breath research.
[7] N. Peled,et al. Screening for Lung Cancer: What Comes Next? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Matthew B Schabath,et al. Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] W. Miekisch,et al. Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[10] P. Mazzone,et al. Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.
[11] C Di Natale,et al. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling. , 2012, Lung cancer.
[12] M. Fiegl,et al. Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.
[13] Hossam Haick,et al. Nanoscale Sensor Technologies for Disease Detection via Volatolomics. , 2015, Small.
[14] G. Sun,et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. , 2010, Lung cancer.
[15] J. Beauchamp,et al. On the use of Tedlar® bags for breath-gas sampling and analysis , 2008, Journal of breath research.
[16] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[17] B. Buszewski,et al. The application of statistical methods using VOCs to identify patients with lung cancer , 2011, Journal of breath research.
[18] Tarek Mekhail,et al. Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[19] J. Austin,et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[20] C. Dolea,et al. World Health Organization , 1949, International Organization.
[21] E. Martinelli,et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. , 2003, Biosensors & bioelectronics.
[22] H. Haick,et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.
[23] Hossam Haick,et al. Volatile organic compounds of lung cancer and possible biochemical pathways. , 2012, Chemical reviews.
[24] Hossam Haick,et al. Detection of cancer through exhaled breath: a systematic review , 2015, Oncotarget.
[25] Magdalena Ligor,et al. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry , 2009, Clinical chemistry and laboratory medicine.
[26] H. J. O’neill,et al. Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.
[27] Ping Wang,et al. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. , 2012, Cancer biomarkers : section A of Disease markers.
[28] Julian King,et al. Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. , 2013, The Analyst.
[29] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[30] W. Miekisch,et al. Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.
[31] Radu Ionescu,et al. Volatile fingerprints of cancer specific genetic mutations. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[32] Hossam Haick,et al. Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. , 2009, Small.
[33] Giorgio Pennazza,et al. The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs , 2015, Scientific Reports.
[34] W. Miekisch,et al. Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[35] Marc Quirynen,et al. Differences between alveolar air and mouth air. , 2007, Analytical chemistry.
[36] H. Haick,et al. Non-invasive Breath Analysis of Pulmonary Nodules , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[37] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[38] A. Onn,et al. Screening for lung cancer: time for large-scale screening by chest computed tomography , 2014, European Respiratory Journal.
[39] Marcus Wolff,et al. VOC breath biomarkers in lung cancer. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[40] Onofrio Resta,et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.
[41] Ulrike Tisch,et al. A nanomaterial-based breath test for short-term follow-up after lung tumor resection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[42] Ulrike Tisch,et al. Classification of lung cancer histology by gold nanoparticle sensors. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[43] Calum E. MacAulay,et al. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose , 2015, IEEE Transactions on Biomedical Engineering.
[44] Giorgio Pennazza,et al. An investigation on electronic nose diagnosis of lung cancer. , 2010, Lung cancer.
[45] Hossam Haick,et al. Assessment, origin, and implementation of breath volatile cancer markers. , 2014, Chemical Society reviews.
[46] John C. Cancilla,et al. Silicon Nanowire Sensors Enable Diagnosis of Patients via Exhaled Breath. , 2016, ACS nano.
[47] John C. Cancilla,et al. Cancerous glucose metabolism in lung cancer—evidence from exhaled breath analysis , 2016, Journal of breath research.
[48] M. Phillips,et al. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening , 2015, PloS one.
[49] Massimo Corradi,et al. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[50] A. Zwinderman,et al. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis , 2014, Journal of Clinical Pathology.
[51] William Hazelton,et al. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force , 2014, Annals of Internal Medicine.
[52] L. Bianchi,et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.
[53] H. Haick,et al. Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules , 2016, ACS nano.
[54] Giorgio Pennazza,et al. Interpretation of exhaled volatile organic compounds , 2010 .
[55] Q. Jöbsis,et al. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review , 2012, Respiratory Research.
[56] Tarek Mekhail,et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array , 2007, Thorax.